Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 2003 Apr;87(4):385–390. doi: 10.1136/bjo.87.4.385

Is ophthalmology evidence based? A clinical audit of the emergency unit of a regional eye hospital

T Y Y Lai 1, V W Y Wong 1, G M Leung 2
PMCID: PMC1771629  PMID: 12642295

Abstract

Aim: To evaluate the proportion of interventions that are evidence based in the acute care unit of a regional eye hospital.

Methods: A prospective clinical audit was carried out at Hong Kong Eye Hospital in July 2002 to investigate the extent to which ophthalmic practices were evidence based. The major diagnosis and intervention provided were identified through chart review. A corresponding literature search using Medline and the Cochrane Library was performed to assess the degree to which each intervention was based on current, best evidence. Each diagnosis intervention pair was accordingly analysed and graded. The level of best, current evidence supporting each intervention was graded and analysed.

Results: A total of 274 consecutive consultation episodes were examined. 22 cases were excluded since no diagnosis or intervention was made during the consultation. 108 (42.9%) patient interventions were found to be based on evidence from systematic reviews, meta-analyses, or randomised controlled trials (RCT). Evidence from prospective or retrospective observational studies supported the interventions in 86 (34.1%) patients. In 58 (23.0%) cases, no evidence or opposing evidence was found regarding the intervention. The proportion of evidence based on RCT or systematic reviews was higher for surgical interventions compared with non-surgical interventions (p=0.007). The proportion of interventions based on RCT or systematic reviews was higher for specialist ophthalmologists than trainee ophthalmologists (p=0.021).

Conclusion: This study demonstrated that the majority of interventions in the ophthalmic unit were evidence based and comparable to the experience of other specialties.

Keywords: evidence based medicine, ophthalmology, Hong Kong


Evidence based medicine (EBM) is the “conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients.”1 The concept of EBM has gained worldwide popularity in the past decade and aims at encouraging clinical practice to be grounded in scientific inquiry.2 In addition to keeping physicians up to date with the most current medical knowledge, EBM also sets out to support the provision of quality care and minimisation of medical error and to facilitate a more equitable provision of services.2–4

As the quality of scientific evidence varies in the literature, examining the study design may provide clues to determine whether and to what degree the findings are valid and conclusive. The Oxford Centre for Evidence-Based Medicine has developed reviews and a “levels of evidence” scheme for classifying studies based on the epidemiologic design.5 Systematic reviews and randomised controlled trials (RCT) are rated as the highest level of evidence followed by cohort studies and case-control studies. Case series and expert opinion give the lowest level of evidence.

Before the 1995 study by Ellis et al, it has been suggested that only 10% to 20% of current medical interventions were supported by scientific evidence.6 Ellis and colleagues demonstrated that 53% of interventions in a general medical unit were based on evidence from RCT, while an additional 29% were based on reliable non-experimental or observational evidence. Although criticisms have been raised about the generalisability of this study, a later study by Michaud et al reported similar findings.7 Subsequent studies in various other specialties including general practice,8 paediatric surgery,9 dermatology,10 anaesthesia,11 and general surgery12 have evaluated the extent to which common interventions were evidence based. Together, these studies estimated the proportion of interventions that were supported by observational and/or experimental studies ranged from 71% to 97%.

To our knowledge, there has been no formal study on the proportion of evidence based interventions in ophthalmology. Furthermore, this type of study has not been performed in any specialty in Asia. The purpose of this study was to investigate the proportion of ophthalmic interventions that were evidence based in a large, regional teaching eye hospital.

PATIENTS AND METHODS

All patients presenting to the acute care unit (that is, emergency department) of Hong Kong Eye Hospital during seven consecutive sessions in July 2002 were prospectively recruited. The hospital is a tertiary ophthalmic centre serving the Kowloon East cluster with a coverage population of approximately 1.6 million out of 6.8 million in Hong Kong. Medical staff consists of four consultants, 13 specialist ophthalmologists, and 21 trainee ophthalmologists. To minimise Hawthorne's phenomenon (the potential bias associated with subjects being aware that they were being observed), none of the participating ophthalmologists involved was aware of the study during the recruitment period. After each session, all medical charts were retrieved for analysis. A predefined, standardised set of data was collected for each consultation including patients' characteristics and the rank of the ophthalmologist who performed the consultation. The primary diagnosis and primary intervention were independently determined by two of the authors (TL and VW) who were not involved in attending the consultations during the study period. The primary diagnosis was defined as the problem recorded for the consultation that was most responsible for the patient's presentation and the primary intervention as the most important attempt to manage or treat the patient in respect to the primary diagnosis.6 The primary interventions were classified as medical interventions which may include conservative or expectant treatment or the use of pharmaceutical products, or as surgical interventions if procedures included open surgery or laser treatment. Cases were excluded when a primary diagnosis could not be ascertained. Patients who refused or did not consent to the prescribed interventions were also excluded. In cases where there was disagreement in assigning diagnosis or intervention, the authors resolved these by consensus.

Literature review was performed after all the diagnosis and intervention pairs were confirmed. The same two authors performed a comprehensive search through Medline (1966 to August 2002) and the Cochrane Library, Issue 3, 2002, independently and disagreement was again settled by consensus. Only publications in English were selected. The evidence obtained was then graded into five hierarchical categories as described by Kingston et al (Table 1).12 This classification is similar to the classification by the Oxford Centre of Evidence-based Medicine, in which systematic reviews or RCT were given the highest level of evidence.5 However, expert opinion was not considered as proper scientific evidence in this classification. When there was more than one article for an intervention, the study with a higher level of evidence was chosen. For articles at the same level, the more recent article was selected.

Table 1.

Levels of evidence according to Kingston et al12 (n=252)

Level Study design No of patients (%)
1 Systematic review 26 (10.3%)
2 Meta-analysis 2 (0.8%)
3 Randomised controlled trial 80 (31.7%)
4 Prospective study 34 (13.5%)
5 Retrospective study 52 (20.6%)
None No evidence or evidence opposed the intervention 58 (23.0%)

Statistical analyses were performed using spss for Windows v 10.0. Categorical outcomes were compared using two tailed Pearson's χ2 test.

RESULTS

During the study period, 274 consultations were performed by 16 different ophthalmologists (five specialist ophthalmologists and 11 trainee ophthalmologists). The mean number of consultations per ophthalmologist was 17.1 (range 9–36). Patients' mean age was 49.5 years (range 1–87 years). Males comprised 51.8% of the sample population. For the ascertainment of the primary diagnosis and the primary intervention, there was agreement between the two authors in 270 of 274 (98.5%) and in 251 of 252 (99.6%) patients respectively. Twenty two (8.0%) patients were excluded since no diagnosis were made during the consultation (Fig 1). In the remaining 252 cases, 26 (10.3%) and two (0.8%) of the interventions were supported by systematic reviews and meta-analyses, respectively (Table 2). Evidence from RCT supported the management of 80 (31.7%) patients (Table 3). Prospective and retrospective observational studies provided evidence for the interventions in 34 (13.5%) and 52 (20.6%) patients, respectively (Tables 4 and 5). The total number of interventions which were evidence based—that is, with level 1 to 5 evidence, was 194 (77.0%).12 For the remaining 58 (23.0%) diagnosis-intervention pairs, no evidence could be identified to substantiate or refute the intervention rendered (Table 6).

Figure 1.

Figure 1

Study organisation.

Table 2.

Interventions based on systematic reviews or meta-analyses (n=28)

Primary diagnosis Primary intervention No of patients Reference
Infective conjunctivitis Topical antibiotics 19 13
Senile cataract Phacoemulsification + implantation of intraocular lens 5 14
Dendritic ulcer due to herpes simplex virus Topical aciclovir 2 15
Primary open angle glaucoma Topical timolol 1 16
Primary pterygium Pterygium excision + conjunctival autograft 1 17

Table 3.

Interventions based on randomised controlled trials (n=80)

Primary diagnosis Primary intervention No of patients Reference
External eye foreign body/rust ring Removal of foreign body 20 18
Chalazion Incision and curettage 19 19
Anterior uveitis Topical steroid 7 20
Allergic conjunctivitis Topical emedastine 4 21
Corneal abrasion Topical chloramphenicol 4 22
Keratoconjunctivitis sicca Topical lubricants 4 23
Acute central serous retinopathy Observation 2 24
Blepharitis Topical chloramphenicol 2 25
Inflamed pterygium Topical steroid 2 26
Acute angle closure glaucoma Nd:YAG laser iridotomy 1 27
Allergic conjunctivitis Topical lodoxamide 1 28
Blepharitis Topical steroid-antibiotic 1 29
Branch retinal vein occlusion with vitreous haemorrhage Panretinal photocoagulation 1 30
Central retinal vein occlusion with neovascular glaucoma Panretinal photocoagulation 1 31
Chlamydial conjunctivitis Topical chlorotetracycline 1 32
Corneal abrasion Bandage contact lens 1 33
Giant cell arteritis Oral prednisolone 1 34
Herpes simplex virus disciform keratitis Topical aciclovir and topical steroid 1 35
Herpes simplex virus iridocyclitis Topical aciclovir and topical steroid 1 36
Macular oedema due to diabetic retinopathy Argon laser focal photocoagulation 1 37
Moderate non-proliferative diabetic retinopathy Observation 1 38
Primary open angle glaucoma Topical betaxolol 1 39
Postoperative viscoelastics induced rise in intraocular pressure Systemic acetazolamide + topical β blocker 1 40
Recurrent corneal erosion syndrome Topical antibiotics 1 41
Rhegmatogenous retinal detachment Pars plana vitrectomy + encircling + intravitreal sulfur hexafluoride gas 1 42

Table 4.

Interventions based on prospective case series (n=34)

Primary diagnosis Primary intervention No of patients Reference
Subconjunctival haemorrhage Measurement of blood pressure 13 43
Exposed/loosened corneal sutures Removal of corneal sutures 10 44
Filamentary keratitis Debridement of corneal filaments 4 45
Posterior capsular opacity Nd:YAG capsulotomy 2 46
Aponeurotic ptosis Correction of ptosis 1 47
Blepharitis Lid hygiene 1 48
Chalazion Warm massage 1 49
Chronic angle closure glaucoma Sequential argon/Nd:YAG laser iridotomy 1 50
Exposure keratopathy Topical lubricants + eyes taping 1 51

Table 5.

Interventions based on retrospective case series (n=52)

Primary diagnosis Primary intervention No of patients Reference
Acute posterior vitreous detachment/floaters Subsequent reassessment 26 52
Corneal chemical injury Topical antibiotics 6 53
Sectorial episcleritis Topical steroid 4 54
Screening for ethambutol toxic optic neuropathy Reassessment 2 55
Sixth nerve palsy due to microvasular disease Observation 2 56
Lattice degeneration Barrier laser 2 57
Acute angle closure glaucoma Systemic acetazolamide 1 58
Exposed scleral buckle Removal of buckle 1 59
Involutional lower lid entropion Entropion correction 1 60
Mooren's ulcer Topical + systemic steroid 1 61
Phacomorphic glaucoma Antiglaucomatous followed by cataract extraction 1 62
Posner-Sclossman syndrome Systemic acetazolamide + topical β blocker 1 63
Preseptal celluitis Oral ampicillin 1 64
Recurrent corneal erosion syndrome Debridement of loosened epithelium 1 65
Silicone oil induced glaucoma Topical β blocker 1 66
Toxic keratopathy Use of non-preserved lubricants 1 67

Table 6.

Interventions in which no evidence was found or evidence found to oppose the intervention (n=58)

Primary diagnosis Primary intervention No of patients Reference
Corneal abrasion Eye patching 7 68
Chalazion Topical steroid 5 None
Blepharitis Topical chlortetracycline 4 None
Blepharitis Topical lubricants 4 69
Chalazion Topical antibiotics 3 None
Corneal abrasion Topical levofloxacin 3 None
Subconjunctival haemorrhage Topical lubricants 3 None
Trichiasis Epilation of trichiasis 3 70
Conjunctival abrasion Topical antibiotics 2 None
Eroded conjunctival concretion Pricking of concretion 2 None
Traumatic microhyphaema Topical steroid 2 71
Blepharitis Topical sulfacetamide 1 72
Blepharitis Topical antazoline + tetrahydrozoline 1 None
Chemical injury Topical lubricants 1 None
Chlamydial conjunctivitis Topical sulfacetamide 1 None
Conjunctiva foreign body Irrigation 1 None
Corneal abrasion Removal of loose epithelium 1 None
Epiphora without nasolacrimal duct obstruction Topical zinc sulfate + naphazoline 1 None
Follicular conjunctivitis Topical chloramphenicol 1 None
Infective conjunctivitis Topical lubricants 1 None
Limbitis with blepharitis Topical steroid + chlortetracycline 1 None
Marginal keratitis Topical steroid 1 None
Nasolacrimal duct obstruction Topical sulfacetamide 1 None
Phlyctenulosis Topical steroid + antibiotics 1 None
Pingueculitis Topical steroid + antibiotics 1 None
Postoperative stitch infiltrate Topical steroid + antibiotics 1 None
Recurrent corneal erosion syndrome Lubricating ointment 1 73
Retained meibomian gland secretions Pricking of secretions 1 None
Retrobulbar optic neuritis Oral prednisolone 1 74
Sectorial episcleritis Topical lubricants 1 None
Subconjunctivial haemorrhage Topical antibiotics 1 None

The primary intervention was classified as a medical intervention in 168 (66.7%) cases, while the remaining 84 (33.3%) cases were surgical interventions. The proportion of interventions that were evidence based was higher in the surgical group compared to the medical group but was not statistically significant (p=0.09). Among the 194 evidence based interventions, the quality of evidence was better in the surgical group with 48 of 70 (68.6%) interventions being supported by RCT or better compared to 60 of 124 (48.4%) interventions in the medical group (p=0.007).

Among all 252 interventions, 65 (25.8%) were delivered by specialist ophthalmologists and 187 (74.2%) were performed by trainee ophthalmologists. There was no difference in the proportion of evidence based interventions performed by the two groups (p=0.50). The respective proportions of medical and surgical interventions performed by each group were also similar (p=0.88). However, the quality of evidence based interventions performed by the specialist group was better compared with the trainee group, with evidence based on RCT or better supporting 36 of 52 (69.2%) interventions and 72 of 142 (50.7%) interventions in the specialist ophthalmologist and the trainee ophthalmologist groups respectively (p=0.021).

A total of 86 different interventions could be identified. The eight most common interventions accounted for the treatment of 121 (48.0%) patients (Table 7). All but one of these interventions were evidence based.

Table 7.

The eight most common interventions accounted for the treatment of 121 patients

Primary diagnosis Primary intervention No of patients Level of evidence
Acute posterior vitreous detachment/floaters Subsequent reassessment 26 Retrospective study
External eye foreign body/rust ring Removal of foreign body 20 RCT
Chalazion Incision and curettage 19 RCT
Infective conjunctivitis Topical antibiotics 19 Systematic review
Subconjunctival haemorrhage Measurement of blood pressure 13 Prospective study
Exposed/loosened corneal sutures Removal of corneal sutures 10 Prospective study
Anterior uveitis Topical steroid 7 RCT
Corneal abrasion Eye patching 7 No evidence

DISCUSSION

Our study demonstrated that the majority of interventions (77.0%) in our regional ophthalmic unit were evidence based. The proportion of evidence based interventions in our study was comparable to findings from studies in other specialties, where around 80% of interventions were found to be grounded in scientific evidence.6–10,12 Furthermore, evidence from RCTs (level 3) or better could be identified in 108 (42.9%) patients. This was also within the range of previous studies, in which 11% to 53% of interventions were found to be based on evidence from RCT or better.6–12

Ophthalmology is a unique specialty in which a mix of both medical and surgical interventions are routinely performed. It is well known that randomised controlled trials are generally harder to conduct for surgical treatments and previous studies have shown that the proportion of evidence from RCTs was lower in surgical studies compared with studies in internal medicine.12 In our study, we found that the proportion of interventions based on RCT or better was significantly higher for surgical interventions compared to non-surgical ophthalmic interventions. This might have been because of the rapid advancement in ophthalmic surgical techniques and new instrumentations, thereby encouraging more RCTs being performed for surgical interventions. In addition, the non-surgical interventions in our study were generally prescribed for less serious and self limiting conditions (for example, subconjunctival haemorrhage, acute posterior vitreous detachment), where it may be difficult or even unnecessary, to carry out RCTs to generate evidence.

Of note, the proportion of interventions with evidence based on RCTs or better was higher in the specialist ophthalmologist group compared with the trainee ophthalmologist group. This may be due to the more experienced specialist group being more aware of the evidence available in the literature. The seniority of the specialist ophthalmologists may also allow them to be involved in the development of clinical guidelines and protocols for the unit and this process would have allowed them to be better equipped in practising EBM. Therefore, our results suggest that the more senior doctors are actually practising EBM rather than “eminence” based medicine as some have previously suggested.75

In this study, we only considered evidence to be valid if it was published in the medical literature. We did not use any textbooks or expert panels as the source of evidence since these sources have been suggested not to constitute “good” evidence and therefore should be excluded from studies of this nature.12 Other potential limitations in our study also bear mention. During the literature review, we may not have identified all the relevant literature since not all available scientific databases were searched, although Medline and the Cochrane library have often been cited as the “gold” standard for this type of study.12,76 Also, language bias may have occurred as only publications in English were assessed. The reductionist approach of having a primary diagnosis and primary intervention pairing may have led to a loss of practical reality in the actual clinical setting. Our clinical setting also made the results less generalisable since the study was conducted within the acute care unit and the proportion of evidence based intervention might differ among different subspecialty clinics as well as between other hospitals. Future research should extend this study methodology to different hospital subspecialty clinics and other centres to increase the external validity and representativeness. Lastly, we only selected the single best study on the basis of the study design for analysis to preserve clarity and simplicity. However, one of the weaknesses of EBM is the heavy emphasis on RCT where other types of evidence may be devalued, making a poor quality RCT more influential than valid non-randomised studies.77 Ideally, the quality of each individual randomised controlled trials should be examined and any conflicting results from various randomised controlled trial should be resolved through systematic reviews or meta-analyses.

In summary, our study has demonstrated that most of the current ophthalmic interventions in the acute care unit of the Hong Kong Eye Hospital were evidence based. Routine audits similar to our study may be beneficial since they can provide quality assurance to the provision of optimal patient care.7 Through this study, we have highlighted areas in which there was limited evidence and have identified areas of deficiency in the literature for future research.

Acknowledgments

We would like to thank Drs CC Chi and NM Lam for their support for the study and Mr John Cheng for retrieving all the medical charts.

Conflicts of interest (financial or otherwise): None.

Financial support: None.

REFERENCES

  • 1.Sackett DL, Rosenberg WC, Muir Gray JA, et al. Evidence-based medicine: what it is and what it isn't. BMJ 1996;312:71–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Leung GM. Evidence-based practice revisited. Asia Pac J Public Health (in press). [DOI] [PubMed]
  • 3.Committee on Quality of Health Care in America, Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press, 2001.
  • 4.Slawson DC, Shaughnessy AF. Using “medical poetry” to remove ithe inequities in health care delivery. J Fam Pract 2001;50:51–6. [PubMed] [Google Scholar]
  • 5.Phillips R, Ball C, Sackett D, et al. Oxford centre of evidence-based medicine level of evidence. November 1998. http://minerva.minervation.com/cebm/docs/levels.html.
  • 6.Ellis J, Mulligan I, Rowe J, et al. Inpatient general medicine is evidence based. Lancet 1995;346:407–10. [PubMed] [Google Scholar]
  • 7.Michaud G, McGowan JL, van der Jagt, R, et al. Are therapeutic decisions supported by evidence from health care research? Arch Intern Med 1998;158:1665–8. [DOI] [PubMed] [Google Scholar]
  • 8.Gill P, Dowell AC, Neal RD, et al. Evidence based general practice: a retrospective study of interventions in one training practice. BMJ 1996;312:819–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kenny SE, Shankar KR, Rintala R, et al. Evidence-based surgery: interventions in a regional paediatric surgical unit. Arch Dis Child 1997;76:50–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jemec GB, Thorsteinsdottir H, Wulf HC. Evidence-based dermatologic out-patient treatment. Int J Dermatol 1998;37:850–4. [DOI] [PubMed] [Google Scholar]
  • 11.Myles PS, Bain DL, Johnson F, et al. Is anaesthesia evidence-based? A survey of anaesthetic practice. Br J Anaesth 1999;82:591–5. [DOI] [PubMed] [Google Scholar]
  • 12.Kingston R, Barry M, Tierney S, et al. Treatment of surgical patients is evidence-based. Eur J Surg 2001;167:324–30. [DOI] [PubMed] [Google Scholar]
  • 13.Sheikh A, Hurwitz B, Cave J. Antibiotics versus placebo for acute bacterial conjunctivitis. In: Cochrane Collaboration. Cochrane Library. Issue 3. Oxford: Update Software, 2002.
  • 14.Snellingen T, Evans JR, Ravilla T, et al. Surgical interventions for age-related cataract. In: Cochrane Collaboration. Cochrane Library. Issue 3. Oxford: Update Software, 2002. [DOI] [PubMed]
  • 15.Wilhelmus KR. Interventions for herpes simplex virus epithelial keratitis. In: Cochrane Collaboration. Cochrane Library. Issue 3. Oxford: Update Software, 2002.
  • 16.Zhang WY, Po AL, Dua HS, et al. Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension. Br J Ophthalmol 2001;85:983–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sanchez-Thorin JC, Rocha G, Yelin JB. Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium. Br J Ophthalmol 1998;82:661–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sigurdsson H, Hanna I, Lockwood AJ, et al. Removal of rust rings, comparing electric drill and hypodermic needle. Eye 1987;1:430–32. [DOI] [PubMed] [Google Scholar]
  • 19.Mustafa TA, Oriafage IH. Three methods of treatment of chalazia in children. Saudi Med J 2001;22:968–72. [PubMed] [Google Scholar]
  • 20.Young BJ, Cunningham WF, Akingbehin T. Double-masked controlled clinical trial of 5% tolmetin versus 0.5% prednisolone versus 0.9% saline in acute endogenous nongranulomatous anterior uveitis. Br J Ophthalmol 1982;66:389–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Verin P, Easty DL, Secchi A, et al. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis. Am J Ophthalmol 2001;131:691–8. [DOI] [PubMed] [Google Scholar]
  • 22.Boberg-Ans G, Nissen KR. Comparison of Fucithalmic viscous eye drops and chloramphenicol eye ointment as a single treatment in corneal abrasion. Acta Ophthalmol Scand 1998;76:108–11. [DOI] [PubMed] [Google Scholar]
  • 23.Marner K, Prause JU. A comparative clinical study of tear substitutes in normal subjects and in patients with keratoconjunctivitis sicca. Acta Ophthalmol (Copenh) 1984;62:91–5. [DOI] [PubMed] [Google Scholar]
  • 24.Khosla PK, Rana SS, Tewari HK, et al. Evaluation of visual function following argon laser photocoagulation in central serous retinopathy. Ophthalmic Surg Lasers 1997;28:693–7. [PubMed] [Google Scholar]
  • 25.Power WJ, Collum LM, Easty DL, et al. Evaluation of efficacy and safety of ciprofloxacin ophthalmic solution versus chloramphenicol. Eur J Ophthalmol 1993;3:77–82. [DOI] [PubMed] [Google Scholar]
  • 26.Frucht-Pery J, Siganos CS, Solomon A, et al. Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study. Am J Ophthalmol 1999;127:148–52. [DOI] [PubMed] [Google Scholar]
  • 27.Fleck BW, Wright E, Fairley EA. A randomised prospective comparison of operative peripheral iridectomy and Nd:YAG laser iridotomy treatment of acute angle closure glaucoma: 3 year visual acuity and intraocular pressure control outcome. Br J Ophthalmol 1997;81:884–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Fahy GT, Easty DL, Collum LM, et al. Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study. Eur J Ophthalmol 1992;2:144–9. [DOI] [PubMed] [Google Scholar]
  • 29.Shulman DG, Sargent JB, Stewart RH, et al. Comparative evaluation of the short-term bactericidal potential of a steroid-antibiotic combination versus steroid in the treatment of chronic bacterial blepharitis and conjunctivitis. Eur J Ophthalmol 1996;6:361–7. [DOI] [PubMed] [Google Scholar]
  • 30.Hayreh SS, Rubenstein L, Podhajsky P. Argon laser scatter photocoagulation in treatment of branch retinal vein occlusion. A prospective clinical trial. Ophthalmologica 1993;206:1–14. [DOI] [PubMed] [Google Scholar]
  • 31.The Central Vein Occlusion Study Group N report. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. Ophthalmology 1995;102:1434–44. [PubMed] [Google Scholar]
  • 32.Darougar S, Viswalingam N, El-Sheikh H, et al. A double-blind comparison of topical therapy of chlamydial ocular infection (TRIC infection) with rifampicin or chlortetracycline. Br J Ophthalmol 1981;65:549–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Donnenfeld ED, Selkin BA, Perry HD, et al. Controlled evaluation of a bandage contact lens and a topical nonsteroidal anti-inflammatory drug in treating traumatic corneal abrasions. Ophthalmology 1995;102:979–84. [DOI] [PubMed] [Google Scholar]
  • 34.Chevalet P, Barrier JH, Pottier P, et al. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients. J Rheumatol 2000;27:1484–91. [PubMed] [Google Scholar]
  • 35.Power WJ, Hillery MP, Benedict-Smith A, et al. Acyclovir ointment plus topical betamethasone or placebo in first episode disciform keratitis. Br J Ophthalmol 1992;76:711–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.The Herpetic Eye Disease Study Group. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. Arch Ophthalmol 1996;114:1065–72. [DOI] [PubMed] [Google Scholar]
  • 37.Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796–806. [PubMed] [Google Scholar]
  • 38.Early Photocoagulation for Diabetic Retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98:766–85. [PubMed] [Google Scholar]
  • 39.Watson PG, Barnett MF, Parker V, et al. A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma. Br J Ophthalmol 2001;85:962–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Duperre J, Grenier B, Lemire J, et al. Effect of timolol vs acetazolamide on sodium hyaluronate-induced rise in intraocular pressure after cataract surgery. Can J Ophthalmol 1994;29:182–6. [PubMed] [Google Scholar]
  • 41.Hykin PG, Foss AE, Pavesio C, et al. The natural history and management of recurrent corneal erosion: a prospective randomised trial. Eye 1994;8:35–40. [DOI] [PubMed] [Google Scholar]
  • 42.Hammer M, Margo CE, Grizzard WS. Complex retinal detachment treated with silicone oil or sulfur hexafluoride gas: a randomized clinical trial. Ophthalmic Surg Lasers 1997;28:926–31. [PubMed] [Google Scholar]
  • 43.Pitts JF, Jardine AG, Murray SB, et al. Spontaneous subconjunctival haemorrhage: a sign of hypertension? Br J Ophthalmol 1992;76:297–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Danjoux JP, Reck AC. Corneal sutures: is routine removal really necessary? Eye 1994;8:339–42. [DOI] [PubMed] [Google Scholar]
  • 45.Arora I, Singhvi S. Impression debridement of corneal lesions. Ophthalmology 1994;101:1935–40. [DOI] [PubMed] [Google Scholar]
  • 46.Bath PE, Fankhauser F. Long-term results of Nd:YAG laser posterior capsulotomy with the Swiss laser. J Cataract Refract Surg 1986;12:150–3. [DOI] [PubMed] [Google Scholar]
  • 47.Linberg JV, Vasquez RJ, Chao GM. Aponeurotic ptosis repair under local anesthesia. Prediction of results from operative lid height. Ophthalmology 1988;95:1046–52. [DOI] [PubMed] [Google Scholar]
  • 48.Key JE. A comparative study of eyelid cleaning regimens in chronic blepharitis. CLAO J 1996;22:209–12. [PubMed] [Google Scholar]
  • 49.Perry HD, Serniuk RA. Conservative treatment of chalazia. Ophthalmology 1980;87:218–21. [DOI] [PubMed] [Google Scholar]
  • 50.Goins K, Schmeisser E, Smith T. Argon laser pretreatment in Nd:YAG iridotomy. Ophthalmic Surg 1990;21:497–500. [PubMed] [Google Scholar]
  • 51.Suresh P, Mercieca F, Morton A, et al. Eye care for the critically ill. Intensive Care Med 2000;26:162–6. [DOI] [PubMed] [Google Scholar]
  • 52.Dayan MR, Jayamanne DG, Andrews RM, et al. Flashes and floaters as predictors of vitreoretinal pathology: is follow-up necessary for posterior vitreous detachment? Eye 1996;10:456–8. [DOI] [PubMed] [Google Scholar]
  • 53.Brodovsky SC, McCarty CA, Snibson G, et al. Management of alkali burns: an 11-year retrospective review. Ophthalmology 2000;107:1829–35. [DOI] [PubMed] [Google Scholar]
  • 54.Jabs DA, Mudun A, Dunn JP, et al. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol 2000;130:469–76. [DOI] [PubMed] [Google Scholar]
  • 55.Russo PA, Chaglasian MA. Toxic optic neuropathy associated with ethambutol: implications for current therapy. J Am Optom Assoc 1994;65:332–8. [PubMed] [Google Scholar]
  • 56.Sanders SK, Kawasaki A, Purvin VA. Long-term prognosis in patients with vasculopathic sixth nerve palsy. Am J Ophthalmol 2002;134:81–4. [DOI] [PubMed] [Google Scholar]
  • 57.Folk JC, Arrindell EL, Klugman MR. The fellow eye of patients with phakic lattice retinal detachment. Ophthalmology 1989;96:72–9. [DOI] [PubMed] [Google Scholar]
  • 58.Choong YF, Irfan S, Menage MJ. Acute angle closure glaucoma: an evaluation of a protocol for acute treatment. Eye 1999;13:613–6. [DOI] [PubMed] [Google Scholar]
  • 59.Smiddy WE, Miller D, Flynn HW Jr. Scleral buckle removal following retinal reattachment surgery: clinical and microbiologic aspects. Ophthalmic Surg 1993;24:440–5. [PubMed] [Google Scholar]
  • 60.Boboridis K, Bunce C, Rose GE. A comparative study of two procedures for repair of involutional lower lid entropion. Ophthalmology 2000;107:959–61. [DOI] [PubMed] [Google Scholar]
  • 61.Brown SI, Mondino BJ. Therapy of Mooren's ulcer. Am J Ophthalmol 1984;98:1–6. [DOI] [PubMed] [Google Scholar]
  • 62.McKibbin M, Gupta A, Atkins AD. Cataract extraction and intraocular lens implantation in eyes with phacomorphic or phacolytic glaucoma. J Cataract Refract Surg 1996;22:633–6. [DOI] [PubMed] [Google Scholar]
  • 63.Hung PT, Chang JM. Treatment of glaucomatocyclitic crises. Am J Ophthalmol 1974;77:169–72. [DOI] [PubMed] [Google Scholar]
  • 64.Smith TF, O'Day D, Wright PF. Clinical implications of preseptal (periorbital) cellulitis in childhood. Pediatrics 1978;62:1006–9. [PubMed] [Google Scholar]
  • 65.Reidy JJ, Paulus MP, Gona S. Recurrent erosions of the cornea: epidemiology and treatment. Cornea 2000;19:767–71. [DOI] [PubMed] [Google Scholar]
  • 66.Gonvers M, Andenmatten R. Temporary silicone oil tamponade and intraocular pressure: an 11-year retrospective study. Eur J Ophthalmol 1996;6:74–80. [DOI] [PubMed] [Google Scholar]
  • 67.Schwab IR, Abbott RL. Toxic ulcerative keratopathy. An unrecognized problem. Ophthalmology 1989;96:1187–93. [DOI] [PubMed] [Google Scholar]
  • 68.Flynn CA, D'Amico F, Smith G. Should we patch corneal abrasions? A meta-analysis. J Fam Pract 1998;47:264–70. [PubMed] [Google Scholar]
  • 69.Moudgil SS, Khurana AK, Singh M, et al. Effect of methyl cellulose on tear film break-up-time in health and disease. Acta Ophthalmol (Copenh) 1987;65:397–9. [DOI] [PubMed] [Google Scholar]
  • 70.Graz B, Xu JM, Yao ZS, et al. Trachoma: can trichiasis be treated with a sticking-plaster? A randomized clinical trial in China. Trop Med Int Health 1999;4:222–8. [DOI] [PubMed] [Google Scholar]
  • 71.Recchia FM, Saluja RK, Hammel K, et al. Outpatient management of traumatic microhyphema. Ophthalmology 2002;109:1465–70. [DOI] [PubMed] [Google Scholar]
  • 72.Foulks GN, Austin R, Knowlton G. Clinical comparison of topical solutions containing trimethoprim in treating ocular surface bacterial infections. J Ocul Pharmacol 1988;4:111–5. [DOI] [PubMed] [Google Scholar]
  • 73.Eke T, Morrison D, Austin DJ. Topical ointment does not prevent recurrent symptoms following traumatic corneal abrasion. Br J Ophthalmol 1998;82:1096–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992;326:581–8. [DOI] [PubMed] [Google Scholar]
  • 75.Issacs D, Fitzgerald D. Seven alternatives to evidence based medicine. BMJ 1999;319:1618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Nordin-Johansson A, Asplund K. Randomized controlled trials and consensus as a basis for interventions in internal medicine. J Intern Med 2000;247:94–104. [DOI] [PubMed] [Google Scholar]
  • 77.Lee JS, Urschel DM, Urschel JD. Is general thoracic surgical practice evidence based. Ann Thorac Surg 2000;70:429–31. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES